000178896 001__ 178896
000178896 005__ 20240229143559.0
000178896 0247_ $$2doi$$a10.1097/HS9.0000000000000688
000178896 0247_ $$2pmid$$apmid:35187406
000178896 0247_ $$2pmc$$apmc:PMC8849404
000178896 0247_ $$2altmetric$$aaltmetric:123450445
000178896 037__ $$aDKFZ-2022-00327
000178896 041__ $$aEnglish
000178896 082__ $$a610
000178896 1001_ $$aLiebers, Nora$$b0
000178896 245__ $$aSeroconversion Rates After the Second COVID-19 Vaccination in Patients With Systemic Light Chain (AL) amyloidosis.
000178896 260__ $$a[Philadelphia, Pennsylvania]$$bWolters Kluwer Health$$c2022
000178896 3367_ $$2DRIVER$$aarticle
000178896 3367_ $$2DataCite$$aOutput Types/Journal article
000178896 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1650631466_2602$$xLetter
000178896 3367_ $$2BibTeX$$aARTICLE
000178896 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000178896 3367_ $$00$$2EndNote$$aJournal Article
000178896 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000178896 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
000178896 7001_ $$aSchönland, Stefan O$$b1
000178896 7001_ $$aSpeer, Claudius$$b2
000178896 7001_ $$0P:(DE-He78)92820b4867c955a04f642707ecf35b40$$aEdelmann, Dominic$$b3$$udkfz
000178896 7001_ $$aSchnitzler, Paul$$b4
000178896 7001_ $$aKräusslich, Hans-Georg$$b5
000178896 7001_ $$aMueller-Tidow, Carsten$$b6
000178896 7001_ $$aHegenbart, Ute$$b7
000178896 7001_ $$aDietrich, Sascha$$b8
000178896 773__ $$0PERI:(DE-600)2922183-3$$a10.1097/HS9.0000000000000688$$gVol. 6, no. 3, p. e688 -$$n3$$pe688$$tHemaSphere$$v6$$x2572-9241$$y2022
000178896 909CO $$ooai:inrepo02.dkfz.de:178896$$pVDB
000178896 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)92820b4867c955a04f642707ecf35b40$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000178896 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000178896 9141_ $$y2022
000178896 915__ $$0LIC:(DE-HGF)CCBYNCNDNV$$2V:(DE-HGF)$$aCreative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND (No Version)$$bDOAJ$$d2020-08-28
000178896 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2020-08-28
000178896 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2020-08-28
000178896 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bHEMASPHERE : 2021$$d2022-11-09
000178896 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-09
000178896 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-09
000178896 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-02-13T18:57:08Z
000178896 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-02-13T18:57:08Z
000178896 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Double blind peer review$$d2021-02-13T18:57:08Z
000178896 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-09
000178896 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-09
000178896 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-09
000178896 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bHEMASPHERE : 2021$$d2022-11-09
000178896 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lC060 Biostatistik$$x0
000178896 980__ $$ajournal
000178896 980__ $$aVDB
000178896 980__ $$aI:(DE-He78)C060-20160331
000178896 980__ $$aUNRESTRICTED